Global Influenza Diagnostics Market Growth 2020-2025

Publisher Name :
Date: 17-Mar-2020
No. of pages: 162

According to this study, over the next five years the Influenza Diagnostics market will register a 6.1% CAGR in terms of revenue, the global market size will reach $ 2843.3 million by 2025, from $ 2241.9 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Influenza Diagnostics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Influenza Diagnostics market by type, application, key manufacturers and key regions and countries.

This study considers the Influenza Diagnostics value and volume generated from the sales of the following segments:

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

- RIDT

- RT-PCR

- Cell Culture

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

- Hospitals

- POCT

- Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

- BD

- Sekisui Diagnostics

- Abbott (Include Alere)

- SIEMENS

- Analytik Jena

- Roche

- Meridian Bioscience

- Quidel

- BioMerieux

- Thermo Fisher

- Response Biomedical

- Focus Diagnostics

- Enigma Diagnostics

- SA Scientific

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Influenza Diagnostics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

- To understand the structure of Influenza Diagnostics market by identifying its various subsegments.

- Focuses on the key global Influenza Diagnostics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Influenza Diagnostics with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Influenza Diagnostics submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Influenza Diagnostics Market Growth 2020-2025

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Influenza Diagnostics Consumption 2015-2025
2.1.2 Influenza Diagnostics Consumption CAGR by Region
2.2 Influenza Diagnostics Segment by Type
2.2.1 RIDT
2.2.2 RT-PCR
2.2.3 Cell Culture
2.3 Influenza Diagnostics Consumption by Type
2.3.1 Global Influenza Diagnostics Consumption Market Share by Type (2015-2020)
2.3.2 Global Influenza Diagnostics Revenue and Market Share by Type (2015-2020)
2.3.3 Global Influenza Diagnostics Sale Price by Type (2015-2020)
2.4 Influenza Diagnostics Segment by Application
2.4.1 Hospitals
2.4.2 POCT
2.4.3 Others
2.5 Influenza Diagnostics Consumption by Application
2.5.1 Global Influenza Diagnostics Consumption Market Share by Type (2015-2020)
2.5.2 Global Influenza Diagnostics Value and Market Share by Type (2015-2020)
2.5.3 Global Influenza Diagnostics Sale Price by Type (2015-2020)

3 Global Influenza Diagnostics by Company
3.1 Global Influenza Diagnostics Sales Market Share by Company
3.1.1 Global Influenza Diagnostics Sales by Company (2018-2020)
3.1.2 Global Influenza Diagnostics Sales Market Share by Company (2018-2020)
3.2 Global Influenza Diagnostics Revenue Market Share by Company
3.2.1 Global Influenza Diagnostics Revenue by Company (2018-2020)
3.2.2 Global Influenza Diagnostics Revenue Market Share by Company (2018-2020)
3.3 Global Influenza Diagnostics Sale Price by Company
3.4 Global Influenza Diagnostics Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Influenza Diagnostics Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Influenza Diagnostics Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Influenza Diagnostics by Regions
4.1 Influenza Diagnostics by Regions
4.2 Americas Influenza Diagnostics Consumption Growth
4.3 APAC Influenza Diagnostics Consumption Growth
4.4 Europe Influenza Diagnostics Consumption Growth
4.5 Middle East & Africa Influenza Diagnostics Consumption Growth

5 Americas
5.1 Americas Influenza Diagnostics Consumption by Countries
5.1.1 Americas Influenza Diagnostics Consumption by Countries (2015-2020)
5.1.2 Americas Influenza Diagnostics Value by Countries (2015-2020)
5.2 Americas Influenza Diagnostics Consumption by Type
5.3 Americas Influenza Diagnostics Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Influenza Diagnostics Consumption by Regions
6.1.1 APAC Influenza Diagnostics Consumption by Regions (2015-2020)
6.1.2 APAC Influenza Diagnostics Value by Regions (2015-2020)
6.2 APAC Influenza Diagnostics Consumption by Type
6.3 APAC Influenza Diagnostics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Influenza Diagnostics by Countries
7.1.1 Europe Influenza Diagnostics Consumption by Countries (2015-2020)
7.1.2 Europe Influenza Diagnostics Value by Countries (2015-2020)
7.2 Europe Influenza Diagnostics Consumption by Type
7.3 Europe Influenza Diagnostics Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Influenza Diagnostics by Countries
8.1.1 Middle East & Africa Influenza Diagnostics Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Influenza Diagnostics Value by Countries (2015-2020)
8.2 Middle East & Africa Influenza Diagnostics Consumption by Type
8.3 Middle East & Africa Influenza Diagnostics Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Influenza Diagnostics Distributors
10.3 Influenza Diagnostics Customer

11 Global Influenza Diagnostics Market Forecast
11.1 Global Influenza Diagnostics Consumption Forecast (2021-2025)
11.2 Global Influenza Diagnostics Forecast by Regions
11.2.1 Global Influenza Diagnostics Forecast by Regions (2021-2025)
11.2.2 Global Influenza Diagnostics Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Influenza Diagnostics Forecast by Type
11.8 Global Influenza Diagnostics Forecast by Application

12 Key Players Analysis
12.1 BD
12.1.1 Company Information
12.1.2 Influenza Diagnostics Product Offered
12.1.3 BD Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 BD Latest Developments
12.2 Sekisui Diagnostics
12.2.1 Company Information
12.2.2 Influenza Diagnostics Product Offered
12.2.3 Sekisui Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sekisui Diagnostics Latest Developments
12.3 Abbott (Include Alere)
12.3.1 Company Information
12.3.2 Influenza Diagnostics Product Offered
12.3.3 Abbott (Include Alere) Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Abbott (Include Alere) Latest Developments
12.4 SIEMENS
12.4.1 Company Information
12.4.2 Influenza Diagnostics Product Offered
12.4.3 SIEMENS Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 SIEMENS Latest Developments
12.5 Analytik Jena
12.5.1 Company Information
12.5.2 Influenza Diagnostics Product Offered
12.5.3 Analytik Jena Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Analytik Jena Latest Developments
12.6 Roche
12.6.1 Company Information
12.6.2 Influenza Diagnostics Product Offered
12.6.3 Roche Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Roche Latest Developments
12.7 Meridian Bioscience
12.7.1 Company Information
12.7.2 Influenza Diagnostics Product Offered
12.7.3 Meridian Bioscience Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Meridian Bioscience Latest Developments
12.8 Quidel
12.8.1 Company Information
12.8.2 Influenza Diagnostics Product Offered
12.8.3 Quidel Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Quidel Latest Developments
12.9 BioMerieux
12.9.1 Company Information
12.9.2 Influenza Diagnostics Product Offered
12.9.3 BioMerieux Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 BioMerieux Latest Developments
12.10 Thermo Fisher
12.10.1 Company Information
12.10.2 Influenza Diagnostics Product Offered
12.10.3 Thermo Fisher Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 Thermo Fisher Latest Developments
12.11 Response Biomedical
12.11.1 Company Information
12.11.2 Influenza Diagnostics Product Offered
12.11.3 Response Biomedical Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.11.4 Main Business Overview
12.11.5 Response Biomedical Latest Developments
12.12 Focus Diagnostics
12.12.1 Company Information
12.12.2 Influenza Diagnostics Product Offered
12.12.3 Focus Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.12.4 Main Business Overview
12.12.5 Focus Diagnostics Latest Developments
12.13 Enigma Diagnostics
12.13.1 Company Information
12.13.2 Influenza Diagnostics Product Offered
12.13.3 Enigma Diagnostics Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.13.4 Main Business Overview
12.13.5 Enigma Diagnostics Latest Developments
12.14 SA Scientific
12.14.1 Company Information
12.14.2 Influenza Diagnostics Product Offered
12.14.3 SA Scientific Influenza Diagnostics Sales, Revenue, Price and Gross Margin (2018-2020)
12.14.4 Main Business Overview
12.14.5 SA Scientific Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology
Table 2. Data Source
Table 3. Influenza Diagnostics Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of RIDT
Table 5. Major Players of RT-PCR
Table 6. Major Players of Cell Culture
Table 7. Global Consumption Sales by Type (2015-2020)
Table 8. Global Influenza Diagnostics Consumption Market Share by Type (2015-2020)
Table 9. Global Influenza Diagnostics Revenue by Type (2015-2020) ($ million)
Table 10. Global Influenza Diagnostics Value Market Share by Type (2015-2020) ($ Millions)
Table 11. Global Influenza Diagnostics Sale Price by Type (2015-2020)
Table 12. Global Consumption Sales by Application (2015-2020)
Table 13. Global Influenza Diagnostics Consumption Market Share by Application (2015-2020)
Table 14. Global Influenza Diagnostics Value by Application (2015-2020)
Table 15. Global Influenza Diagnostics Value Market Share by Application (2015-2020)
Table 16. Global Influenza Diagnostics Sale Price by Application (2015-2020)
Table 17. Global Influenza Diagnostics Sales by Company (2017-2019) (K Units)
Table 18. Global Influenza Diagnostics Sales Market Share by Company (2017-2019)
Table 19. Global Influenza Diagnostics Revenue by Company (2017-2019) ($ Millions)
Table 20. Global Influenza Diagnostics Revenue Market Share by Company (2017-2019)
Table 21. Global Influenza Diagnostics Sale Price by Company (2017-2019)
Table 22. Global Influenza Diagnostics Manufacturing Base Distribution and Sales Area by Manufacturers
Table 23. Players Influenza Diagnostics Products Offered
Table 24. Influenza Diagnostics Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 25. Global Influenza Diagnostics Consumption by Regions 2015-2020 (K Units)
Table 26. Global Influenza Diagnostics Consumption Market Share by Regions 2015-2020
Table 27. Global Influenza Diagnostics Value by Regions 2015-2020 ($ Millions)
Table 28. Global Influenza Diagnostics Value Market Share by Regions 2015-2020
Table 29. Americas Influenza Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 30. Americas Influenza Diagnostics Consumption Market Share by Countries (2015-2020)
Table 31. Americas Influenza Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 32. Americas Influenza Diagnostics Value Market Share by Countries (2015-2020)
Table 33. Americas Influenza Diagnostics Consumption by Type (2015-2020) (K Units)
Table 34. Americas Influenza Diagnostics Consumption Market Share by Type (2015-2020)
Table 35. Americas Influenza Diagnostics Consumption by Application (2015-2020) (K Units)
Table 36. Americas Influenza Diagnostics Consumption Market Share by Application (2015-2020)
Table 37. APAC Influenza Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 38. APAC Influenza Diagnostics Consumption Market Share by Countries (2015-2020)
Table 39. APAC Influenza Diagnostics Value by Regions (2015-2020) ($ Millions)
Table 40. APAC Influenza Diagnostics Value Market Share by Regions (2015-2020)
Table 41. APAC Influenza Diagnostics Consumption by Type (2015-2020) (K Units)
Table 42. APAC Influenza Diagnostics Consumption Market Share by Type (2015-2020)
Table 43. APAC Influenza Diagnostics Consumption by Application (2015-2020) (K Units)
Table 44. APAC Influenza Diagnostics Consumption Market Share by Application (2015-2020)
Table 45. Europe Influenza Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 46. Europe Influenza Diagnostics Consumption Market Share by Countries (2015-2020)
Table 47. Europe Influenza Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 48. Europe Influenza Diagnostics Value Market Share by Countries (2015-2020)
Table 49. Europe Influenza Diagnostics Consumption by Type (2015-2020) (K Units)
Table 50. Europe Influenza Diagnostics Consumption Market Share by Type (2015-2020)
Table 51. Europe Influenza Diagnostics Consumption by Application (2015-2020) (K Units)
Table 52. Europe Influenza Diagnostics Consumption Market Share by Application (2015-2020)
Table 53. Middle East & Africa Influenza Diagnostics Consumption by Countries (2015-2020) (K Units)
Table 54. Middle East & Africa Influenza Diagnostics Consumption Market Share by Countries (2015-2020)
Table 55. Middle East & Africa Influenza Diagnostics Value by Countries (2015-2020) ($ Millions)
Table 56. Middle East & Africa Influenza Diagnostics Value Market Share by Countries (2015-2020)
Table 57. Middle East & Africa Influenza Diagnostics Consumption by Type (2015-2020) (K Units)
Table 58. Middle East & Africa Influenza Diagnostics Consumption Market Share by Type (2015-2020)
Table 59. Middle East & Africa Influenza Diagnostics Consumption by Application (2015-2020) (K Units)
Table 60. Middle East & Africa Influenza Diagnostics Consumption Market Share by Application (2015-2020)
Table 61. Influenza Diagnostics Distributors List
Table 62. Influenza Diagnostics Customer List
Table 63. Global Influenza Diagnostics Consumption Forecast by Countries (2021-2025) (K Units)
Table 64. Global Influenza Diagnostics Consumption Market Forecast by Regions
Table 65. Global Influenza Diagnostics Value Forecast by Countries (2021-2025) ($ Millions)
Table 66. Global Influenza Diagnostics Value Market Share Forecast by Regions
Table 67. Global Influenza Diagnostics Consumption Forecast by Type (2021-2025) (K Units)
Table 68. Global Influenza Diagnostics Consumption Market Share Forecast by Type (2021-2025)
Table 69. Global Influenza Diagnostics Value Forecast by Type (2021-2025) ($ Millions)
Table 70. Global Influenza Diagnostics Value Market Share Forecast by Type (2021-2025)
Table 71. Global Influenza Diagnostics Consumption Forecast by Application (2021-2025) (K Units)
Table 72. Global Influenza Diagnostics Consumption Market Share Forecast by Application (2021-2025)
Table 73. Global Influenza Diagnostics Value Forecast by Application (2021-2025) ($ Millions)
Table 74. Global Influenza Diagnostics Value Market Share Forecast by Application (2021-2025)
Table 75. BD Product Offered
Table 76. BD Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 77. BD Main Business
Table 78. BD Latest Developments
Table 79. BD Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 80. Sekisui Diagnostics Product Offered
Table 81. Sekisui Diagnostics Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 82. Sekisui Diagnostics Main Business
Table 83. Sekisui Diagnostics Latest Developments
Table 84. Sekisui Diagnostics Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 85. Abbott (Include Alere) Product Offered
Table 86. Abbott (Include Alere) Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 87. Abbott (Include Alere) Main Business
Table 88. Abbott (Include Alere) Latest Developments
Table 89. Abbott (Include Alere) Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 90. SIEMENS Product Offered
Table 91. SIEMENS Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 92. SIEMENS Main Business
Table 93. SIEMENS Latest Developments
Table 94. SIEMENS Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 95. Analytik Jena Product Offered
Table 96. Analytik Jena Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 97. Analytik Jena Main Business
Table 98. Analytik Jena Latest Developments
Table 99. Analytik Jena Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 100. Roche Product Offered
Table 101. Roche Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 102. Roche Main Business
Table 103. Roche Latest Developments
Table 104. Roche Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 105. Meridian Bioscience Product Offered
Table 106. Meridian Bioscience Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 107. Meridian Bioscience Main Business
Table 108. Meridian Bioscience Latest Developments
Table 109. Meridian Bioscience Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 110. Quidel Product Offered
Table 111. Quidel Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 112. Quidel Main Business
Table 113. Quidel Latest Developments
Table 114. Quidel Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 115. BioMerieux Product Offered
Table 116. BioMerieux Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 117. BioMerieux Main Business
Table 118. BioMerieux Latest Developments
Table 119. BioMerieux Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 120. Thermo Fisher Product Offered
Table 121. Thermo Fisher Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 122. Thermo Fisher Main Business
Table 123. Thermo Fisher Latest Developments
Table 124. Thermo Fisher Basic Information, Company Total Revenue (in $ million), Influenza Diagnostics Manufacturing Base, Sales Area and Its Competitors
Table 125. Response Biomedical Product Offered
Table 126. Response Biomedical Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 127. Response Biomedical Main Business
Table 128. Response Biomedical Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 129. Response Biomedical Latest Developments
Table 130. Focus Diagnostics Product Offered
Table 131. Focus Diagnostics Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 132. Focus Diagnostics Main Business
Table 133. Focus Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 134. Focus Diagnostics Latest Developments
Table 135. Enigma Diagnostics Product Offered
Table 136. Enigma Diagnostics Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 137. Enigma Diagnostics Main Business
Table 138. Enigma Diagnostics Latest Developments
Table 139. Enigma Diagnostics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table 140. SA Scientific Product Offered
Table 141. SA Scientific Influenza Diagnostics Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 142. SA Scientific Main Business
Table 143. SA Scientific Latest Developments
Table 144. SA Scientific Basic Information, Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Influenza Diagnostics
Figure 2. Influenza Diagnostics Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Influenza Diagnostics Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Influenza Diagnostics Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of RIDT
Figure 7. Product Picture of RT-PCR
Figure 8. Product Picture of Cell Culture
Figure 9. Global Influenza Diagnostics Consumption Market Share by Type (2015-2020)
Figure 10. Global Influenza Diagnostics Value Market Share by Type (2015-2020)
Figure 11. Influenza Diagnostics Consumed in Hospitals
Figure 12. Global Influenza Diagnostics Market: Hospitals (2015-2020) (K Units)
Figure 13. Global Influenza Diagnostics Market: Hospitals (2015-2020) ($ Millions)
Figure 14. Influenza Diagnostics Consumed in POCT
Figure 15. Global Influenza Diagnostics Market: POCT (2015-2020) (K Units)
Figure 16. Global Influenza Diagnostics Market: POCT (2015-2020) ($ Millions)
Figure 17. Influenza Diagnostics Consumed in Others
Figure 18. Global Influenza Diagnostics Market: Others (2015-2020) (K Units)
Figure 19. Global Influenza Diagnostics Market: Others (2015-2020) ($ Millions)
Figure 20. Global Influenza Diagnostics Consumption Market Share by Application (2015-2020)
Figure 21. Global Influenza Diagnostics Value Market Share by Application (2015-2020)
Figure 22. Global Influenza Diagnostics Sales Market Share by Company in 2017
Figure 23. Global Influenza Diagnostics Sales Market Share by Company in 2019
Figure 24. Global Influenza Diagnostics Revenue Market Share by Company in 2017
Figure 25. Global Influenza Diagnostics Revenue Market Share by Company in 2019
Figure 26. Global Influenza Diagnostics Sale Price by Company in 2019
Figure 27. Global Influenza Diagnostics Consumption Market Share by Regions 2015-2020
Figure 28. Global Influenza Diagnostics Value Market Share by Regions 2015-2020
Figure 29. Americas Influenza Diagnostics Consumption 2015-2020 (K Units)
Figure 30. Americas Influenza Diagnostics Value 2015-2020 ($ Millions)
Figure 31. APAC Influenza Diagnostics Consumption 2015-2020 (K Units)
Figure 32. APAC Influenza Diagnostics Value 2015-2020 ($ Millions)
Figure 33. Europe Influenza Diagnostics Consumption 2015-2020 (K Units)
Figure 34. Europe Influenza Diagnostics Value 2015-2020 ($ Millions)
Figure 35. Middle East & Africa Influenza Diagnostics Consumption 2015-2020 (K Units)
Figure 36. Middle East & Africa Influenza Diagnostics Value 2015-2020 ($ Millions)
Figure 37. Americas Influenza Diagnostics Consumption Market Share by Countries in 2019
Figure 38. Americas Influenza Diagnostics Value Market Share by Countries in 2019
Figure 39. Americas Influenza Diagnostics Consumption Market Share by Type in 2019
Figure 40. Americas Influenza Diagnostics Consumption Market Share by Application in 2019
Figure 41. United States Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 42. United States Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 43. Canada Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 44. Canada Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 45. Mexico Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 46. Mexico Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 47. APAC Influenza Diagnostics Consumption Market Share by Countries in 2019
Figure 48. APAC Influenza Diagnostics Value Market Share by Regions in 2019
Figure 49. APAC Influenza Diagnostics Consumption Market Share by Type in 2019
Figure 50. APAC Influenza Diagnostics Consumption Market Share by Application in 2019
Figure 51. China Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 52. China Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 53. Japan Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 54. Japan Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 55. Korea Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 56. Korea Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 57. Southeast Asia Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 58. Southeast Asia Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 59. India Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 60. India Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 61. Australia Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 62. Australia Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 63. Europe Influenza Diagnostics Consumption Market Share by Countries in 2019
Figure 64. Europe Influenza Diagnostics Value Market Share by Countries in 2019
Figure 65. Europe Influenza Diagnostics Consumption Market Share by Type in 2019
Figure 66. Europe Influenza Diagnostics Consumption Market Share by Application in 2019
Figure 67. Germany Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 68. Germany Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 69. France Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 70. France Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 71. UK Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 72. UK Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 73. Italy Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 74. Italy Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 75. Russia Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 76. Russia Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 77. Spain Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 78. Spain Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 79. Middle East & Africa Influenza Diagnostics Consumption Market Share by Countries in 2019
Figure 80. Middle East & Africa Influenza Diagnostics Value Market Share by Countries in 2019
Figure 81. Middle East & Africa Influenza Diagnostics Consumption Market Share by Type in 2019
Figure 82. Middle East & Africa Influenza Diagnostics Consumption Market Share by Application in 2019
Figure 83. Egypt Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 84. Egypt Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 85. South Africa Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 86. South Africa Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 87. Israel Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 88. Israel Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 89. Turkey Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 90. Turkey Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 91. GCC Countries Influenza Diagnostics Consumption Growth 2015-2020 (K Units)
Figure 92. GCC Countries Influenza Diagnostics Value Growth 2015-2020 ($ Millions)
Figure 93. Global Influenza Diagnostics Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 94. Global Influenza Diagnostics Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 95. Americas Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 96. Americas Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 97. APAC Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 98. APAC Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 99. Europe Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 100. Europe Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 101. Middle East & Africa Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 102. Middle East & Africa Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 103. United States Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 104. United States Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 105. Canada Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 106. Canada Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 107. Mexico Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 108. Mexico Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 109. Brazil Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 110. Brazil Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 111. China Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 112. China Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 113. Japan Influenza Diagnostics Consumption 2021-2025 (K Units)
Figure 114. Japan Influenza Diagnostics Value 2021-2025 ($ Millions)
Figure 115. Korea Influenza Diagnostics Consumption 2
  • Global Influenza Diagnostics Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 85
    Influenza is an infectious disease and affects The upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to The influenza B virus. The B virus is responsible for 20% to 25% of infections globally. Proper collection, storage and transport of respiratory specimens are The essential first step for laboratory detection of influenz......
  • Global Tuberculosis (TB) Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 107
    According to our LPI (LP Information) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at US$ 2572.8 million in 2023. With growing demand in downstream market, the Tuberculosis (TB) Diagnostics is forecast to a readjusted size of US$ 3540.9 million by 2030 with a CAGR of 4.7% during review period. The research report highlights the growth potential of the global Tuberculosis (TB) Diagnostics market. Tuberculosis (TB) Diagnostics are expected to show stable gr......
  • Global POC Diagnostics Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 128
    According to our LPI (LP Information) latest study, the global POC Diagnostics market size was valued at US$ 25110 million in 2023. With growing demand in downstream market, the POC Diagnostics is forecast to a readjusted size of US$ 48170 million by 2030 with a CAGR of 9.8% during review period. The research report highlights the growth potential of the global POC Diagnostics market. POC Diagnostics are expected to show stable growth in the future market. However, product differentiatio......
  • Global Allergy Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 109
    According to our LPI (LP Information) latest study, the global Allergy Diagnostics market size was valued at US$ 5070.7 million in 2023. With growing demand in downstream market, the Allergy Diagnostics is forecast to a readjusted size of US$ 10550 million by 2030 with a CAGR of 11.0% during review period. The research report highlights the growth potential of the global Allergy Diagnostics market. Allergy Diagnostics are expected to show stable growth in the future market. However, prod......
  • Global Influenza Diagnostics Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 100
    According to our LPI (LP Information) latest study, the global Influenza Diagnostics market size was valued at US$ 2284.7 million in 2023. With growing demand in downstream market, the Influenza Diagnostics is forecast to a readjusted size of US$ 3558.7 million by 2030 with a CAGR of 6.5% during review period. The research report highlights the growth potential of the global Influenza Diagnostics market. Influenza Diagnostics are expected to show stable growth in the future market. Howev......
  • Global Tuberculosis (TB) Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 112
    According to our (Global Info Research) latest study, the global Tuberculosis (TB) Diagnostics market size was valued at USD 2706.1 million in 2023 and is forecast to a readjusted size of USD 3635.2 million by 2030 with a CAGR of 4.3% during review period. Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, i......
  • Global Influenza Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 111
    According to our (Global Info Research) latest study, the global Influenza Diagnostics market size was valued at USD 2403.1 million in 2023 and is forecast to a readjusted size of USD 3620.3 million by 2030 with a CAGR of 6.0% during review period. Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus......
  • Global Point-of-Care Diagnostics Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 12-Dec-2023        Price: US 3380 Onwards        Pages: 122
    Market Overview of Global Point-of-Care Diagnostics market: According to our latest research, the global Point-of-Care Diagnostics market looks promising in the next 5 years. As of 2022, the global Point-of-Care Diagnostics market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the glo......
  • Global Viral Disease Diagnosis Professional Survey Report 2023, Forecast to 2028
    Published: 27-Nov-2023        Price: US 3280 Onwards        Pages: 105
    They have been used as an alternative method of diagnosing viral diseases. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared acr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs